Polycystin-1, the protein defective in a majority of patients with autosomal dominant polycystic kidney disease, is a ubiquitously expressed multi-span transmembrane protein of unknown function. Subcellular localization studies found this protein to be a component of various cell junctional complexes and to be associated with the cytoskeleton, but the specificity and nature of such associations are not known. To identify proteins that interact with the polycystin-1 C-tail (P1CT), this segment was used as bait in a yeast two-hybrid screening of a kidney epithelial cell library. The intermediate filament (IF) protein vimentin was identified as a strong polycystin-1-interacting partner. Cytokeratins K8 and K18 and desmin were also found to interact with P1CT. These interactions were mediated by coiled-coil motifs in polycystin-1 and IF proteins. Vimentin, cytokeratins K8 and K18, and desmin also bound directly to P1CT in GST pull-down and in in vitro filament assembly assays. Two observations confirmed these interactions in vivo: (i) a cell membrane-anchored form of recombinant P1CT decorated the IF network and was found to associate with the cytoskeleton in detergent-solubilized cells and (ii) endogenous polycystin-1 distributed with IF at desmosomal junctions. Polycystin-1 may utilize this association for structural, storage, or signaling functions.
Autosomal dominant polycystic kidney disease (ADPKD)1 is one of the most common genetic diseases in humans, affecting ϳ1 in 400 individuals and accounting for 8 -10% of end stage renal disease (1). ADPKD is characterized by the formation and progressive expansion of cysts in ductal organs including both kidneys as well as by cardiovascular abnormalities. About 85% of ADPKD cases are caused by defects in polycystin-1 (2, 3), a broadly expressed and developmentally regulated multi-span transmembrane protein with a large extracellular region rich in protein-protein and protein-carbohydrate interaction modules. Although this composition is suggestive of a role in cellcell and/or cell-matrix adhesion, the precise function(s) mediated by polycystin-1 remains unknown.Genetic, immunochemical, and biochemical studies have suggested that polycystin-1 is involved in maintaining the structural integrity of cell-cell junctions in vascular and epithelial structures. In mouse models of ADPKD, mouse embryos lacking a functional polycystin-1 are uniformly edematous (4, 5) and die in utero of hemorrhages preceded by vascular leaks (4). Consistent with these data, polycystin-1 has been shown to distribute at apicolateral cell junctions in both epithelial and endothelial cells (6 -9). Immunolocalization and/or cell fractionation studies found polycystin-1 at tight (10), adherens (7), and desmosomal (9) junctions, at focal contacts (11), and in the cytoplasm. A fraction has also been found in the Triton X-100-insoluble cell fraction, reflecting a strong association with cytoskeleton (12). Recently polycystin-1 was shown to be transported through a tuberin-dependent pathway to the lateral ...
Our results with elderly patients in a nursing home show an excellent patient and technique survival and a low peritonitis rate. With appropriate training of the NH nursing staff, peritoneal dialysis could be performed successfully in these nursing homes. Successful peritoneal dialysis in a nursing home requires a close collaboration between the nursing home staff and PD dialysis unit.
Referral to a nephrology clinic can lead not only to arrest of progression of CKD but also to regression/improvement. Early referral is a positive predictive factor for improvement in eGFR, which emphasizes the importance of such referral. The previously held idea that, once established, CKD progresses invariably is not valid anymore.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.